Home › Germ Cell and Embryonal Cancer › New York › New York City
Germ Cell and Embryonal Cancer clinical trials in New York City, NY
5 studies for Germ Cell and Embryonal Cancer are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of ZW251 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center, New York
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
RecruitingPhase 3
- Memorial Sloan Kettering Cancer Centre, New York
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
RecruitingPhase 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai Hospital, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- and 1 more
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RecruitingPhase 1
- Icahn School of Medicine at Mount Sinai, New York
Germ Cell Tumor and Testicular Tumor DNA Registry
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Cancer Center, New York
Germ Cell and Embryonal Cancer trials in other cities
- Houston, TX6 studies
- Columbus, OH5 studies
- Chicago, IL4 studies
- St. Louis, MO4 studies
- Indianapolis, IN4 studies
- Dallas, TX3 studies
- Memphis, TN3 studies
- Boston, MA3 studies
- Winston-Salem, NC3 studies
- Greenburgh, NY3 studies
- San Antonio, TX3 studies
- San Francisco, CA3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.